Dock Trials definition

Dock Trials means the testing of any portion of the Work by Builder or Owner prior to, and as a condition of, Delivery as described in Section 13.1(a) and in the Specifications.
Sample 1
Dock Trials means the testing of any portion of the Work by Builder or Owner prior to, and as a condition to Delivery. “Effective Date”– shall be the date upon which this Agreement has been signed by both parties hereto and Owner has made payment of the initial Interim Installment Payment in accordance with Exhibit Q.
Sample 1

Examples of Dock Trials in a sentence

  • All supporting documentation shall be submitted to support of the following Key Events: Undocking (if applicable), Propulsion Plant Production Completion Date (PCD), Combat Systems Production Completion Date (CSPCD) or AEGIS Light-Off (ALO) for AEGIS ships, Dock Trials (DT), Fast Cruise (FC), Sea Trials (ST), and Availability Completion (CA).

  • The following key events shall be considered at a minimum (as applicable): Undocking, Propulsion Plant Production Completion Date (PCD), Combat Systems Production Completion Date (CSPCD) or AEGIS Light- Off (ALO) for AEGIS ships, Dock Trials (DT), Fast Cruise (FC), Sea Trials (ST), and Availability Completion (AC).

  • The following key events must be considered at a minimum (as applicable): Undocking, Production Completion Date (PCD), Command, Control, Communications, Computer, Combat Systems, and Intelligence (C5I) Light-Off (C5ILO), Dock Trials (DT), Fast Cruise (FC), Sea Trials (ST), and Availability Completion (AC).

  • The following key events shall be considered at a minimum (as applicable): Undocking, Production Completion Date (PCD), | Command, Control, Communications, Computer, Combat Systems, and Intelligence (C5I) Light-Off (C5ILO), Dock Trials (DT), Fast Cruise (FC), Sea Trials (ST), and Availability Completion (AC).

  • The following key events must be considered at a minimum (as applicable): Undocking, Production Completion Date (PCD), Command, Control, Communications, Computer, Combat Systems, and Intelligence (C5I) Light-Off (C5ILO), Work Complete (WC), Dock Trials (DT), Fast Cruise (FC), Sea Trials (ST), and Availability Completion (AC).

  • Canada may, as a result of the Vessel Bid Confirmation Assessment Phase 1 Inspections and Dock Trials, reduce the score of the Bidder on any rated requirement, if the Vessel Bid Confirmation Assessment Phase 1 Inspections and Dock Trials indicates that the score provided to the Bidder on the basis of its written bid is not validated by the Vessel Bid Confirmation Assessment Phase 1 Inspections and Dock Trials.

  • Dock Trials (DT) are conducted to determine the ship’s readiness to safely go to sea.

  • Dock Trials shall be performed as part of the Provisional and Final Acceptances.

  • All deficiencies, including cracks, leaks, grounds detected in new circuits, or poor workmanship shall be corrected prior to commencement of the Builder’s Dock Trials.

  • The Phase 2 Dock Trials must be conducted, at no cost to Canada, at a location chosen by the Bidder.

Related to Dock Trials

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Commercial Development Plan means the written commercialization plan attached as Appendix E.

  • Contact therapy system means a therapeutic radiation machine with a short target to skin distance (TSD), usually less than five centimeters.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Radiopharmaceutical quality assurance means, but is not limited to, the performance of appropriate chemical, biological, and physical tests on potential radiopharmaceuticals and the interpretation of the resulting data to determine their suitability for use in humans and animals, including internal test assessment, authentication of product history, and the keeping of proper records.

  • System Impact Study means an assessment by the Transmission Provider of (i) the adequacy of the Transmission System to accommodate a Completed Application, an Interconnection Request or an Upgrade Request, (ii) whether any additional costs may be incurred in order to provide such transmission service or to accommodate an Interconnection Request, and (iii) with respect to an Interconnection Request, an estimated date that an Interconnection Customer’s Customer Facility can be interconnected with the Transmission System and an estimate of the Interconnection Customer’s cost responsibility for the interconnection; and (iv) with respect to an Upgrade Request, the estimated cost of the requested system upgrades or expansion, or of the cost of the system upgrades or expansion, necessary to provide the requested incremental rights. System Protection Facilities: “System Protection Facilities” shall refer to the equipment required to protect (i) the Transmission System, other delivery systems and/or other generating systems connected to the Transmission System from faults or other electrical disturbance occurring at or on the Customer Facility, and (ii) the Customer Facility from faults or other electrical system disturbance occurring on the Transmission System or on other delivery systems and/or other generating systems to which the Transmission System is directly or indirectly connected. System Protection Facilities shall include such protective and regulating devices as are identified in the Applicable Technical Requirements and Standards or that are required by Applicable Laws and Regulations or other Applicable Standards, or as are otherwise necessary to protect personnel and equipment and to minimize deleterious effects to the Transmission System arising from the Customer Facility. Transmission Facilities:

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • site development plan means a dimensioned plan drawn to scale that indicates details of the proposed land development, including the site layout, positioning of buildings and structures, property access, building designs and landscaping;

  • Development Program means the implementation of the development plan.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase 1 Trial means, with respect to a Licensed Product, a clinical trial (or — in case of a multi-phase clinical trial — those parts of a clinical trial) in line with the provisions of 21CFR312, Section 21 (a).

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Development Phase means the period before a vehicle type is type approved.

  • Research facility means buildings and structures, including machinery and equipment, used or to be used primarily for research or experimentation to improve or develop new tangible goods or materials or to improve or develop the production processes thereto.

  • Development Plan has the meaning set forth in Section 3.2.

  • Phase 2 Trial means a human clinical trial conducted on study subjects with the disease or condition being studied for the principal purpose of achieving a preliminary determination of efficacy or appropriate dosage ranges, as further described in 21 C.F.R. §312.21(b) (including any such clinical study in any country other than the United States).

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Commercial Launch means the initial First Commercial Sale of a Product in the Territory.

  • Development Site means any parcel or lot on which exists or which is intended for building development other than the following:

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Pivotal Clinical Trial means, with respect to a Licensed Product, (a) a phase 3 Clinical Trial or (b) any other clinical trial that is intended (as of the time the study is initiated) to obtain the results and data to support (without the need to conduct any additional clinical trial) the filing of an application for Regulatory Approval for such product.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Commercialization Plan has the meaning set forth in Section 6.2.